Skip to main content

Advertisement

Figure 2 | BMC Infectious Diseases

Figure 2

From: Integrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites

Figure 2

MDA recommendations for schistosomiasis and trachoma for the 21 sentinel sites from observed data on prevalence of the two diseases; low S. haematobium prevalence (< 10%) and low trachoma prevalence (< 10%) (white markers; no MDA recommended); low S. haematobium prevalence (< 10%) and high trachoma prevalence (> 10%) (yellow markers; MDA for trachoma is recommended); medium S. haematobium prevalence (10-49%) and high trachoma prevalence (> 10%) (red markers; MDA in school-aged children; community MDA for trachoma).

Back to article page